The impact of design and performance in PSA screening: differences between ERSPC centers

The European Randomized study of Screening for Prostate Cancer (ERSPC) has shown a 20% relative reduction in prostate cancer mortality after 16 years (rate ratio RR 0.80), but centers varied by attendance, screen interval, biopsy compliance, contamination in the control arm and treatments. We used a...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Eur Urol
Main Authors: Heijnsdijk, Eveline A.M., Adolfsson, Jan, Auvinen, Anssi, Roobol, Monique J., Hugosson, Jonas, de Koning, Harry J.
Format: Artigo
Jezik:Inglês
Izdano: 2019
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6800079/
https://ncbi.nlm.nih.gov/pubmed/31031050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2019.04.007
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki